Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That is Refractory to Radioactive Iodine (RAI) Treatment

Sussman, M ; Munsell, M ; Valderrama, A ; Seal, B.S ; Wen, L

Value in health, 2014-11, Vol.17 (7), p.A621-A621 [Periódico revisado por pares]

United States

Texto completo disponível